Tag: MDMA

“Our goal is to train psychedelic therapists from a humanistic approach.”

BMed Global was born with the vocation of training many of these professionals in psychedelic therapy, as explained in this interview by its founder, transpersonal psychologist Karina Bertolotto. “We are going to need 100,000 psychedelic therapists in the next few years,” says Rick Doblin, the founder of MAPS and one of the key people in the current ‘Psychedelic Renaissance’. BMed Global was born with the vocation of training many of these professionals in psychedelic therapy, as explained in this interview by its founder, transpersonal psychologist Karina Bertolotto. Here...

Continue reading

“Mental health drugs are like driving a car with both the accelerator and the brake pressed at the same time”

The Barcelona-based Andero Lab has received a Leonardo grant of 40,000 euros from Fundación BBVA for its research into the physiology and treatment of traumatic stress. In an interview published by El País, its founder, neuroscientist Raúl Andero Galí, explains what is known today about this pathology and the limitations offered by current psychiatric drugs to treat this and other ailments: “The drugs now available in mental health, for non-neurological psychiatric disorders, are anxiolytics, to treat anxiety, and antidepressants. These drugs target receptors that are expressed almost...

Continue reading

The pioneering MDMA study that would have put Spain at the forefront of the psychedelic renaissance

In the next year or two, MDMA will become the first psychedelic drug to be approved as a psychiatric medication by the FDA in the United States. This has been made possible by the perseverance of Rick Doblin and his long-time organisation, MAPS, which has spent years and hundreds of millions of dollars on scientific studies to prove that this molecule, known on the street as “ecstasy“, is effective in the treatment of post-traumatic stress disorder, among other promising applications. Twenty-five years ago, in the late 1990s, a pioneering study carried out in Spain reached (or,...

Continue reading

‘How to Change Your Mind’, the Netflix series that’s set to boost the Psychedelic Renaissance

Last week, Netflix began airing ‘How to Change Your Mind’, the four-episode miniseries about psychedelics based on the book of the same name by Michael Pollan and presented by and starring the writer himself, who over the last five years has become a true champion of the so-called Psychedelic Renaissance. Pollan was already an acclaimed and best-selling author thanks to his books on food and, more generally, on the relationship between human beings and the plant kingdom. As he recounts in ‘How to change your mind’, Pollan had never tried a psychedelic drug until the...

Continue reading

The New Dawn of Psychedelic Medicine

Las drogas psicodélicas están de vuelta, si es que alguna vez se fueron del todo. La prohibición de los psicodélicos en 1971 supuso un frenazo en las prometedoras investigaciones que se estaban haciendo en psiquiatría en torno al LSD y otras sustancias durante las décadas de los 50 y 60 del siglo pasado. La epidemia de soledad, depresión, duelo y quiebra social que ha provocado la pandemia del coronavirus ha abonado el terreno para que la poderosa herramienta que son los psicodélicos dé un paso al frente. Un planeta devastado y una población abatida necesita nuevas herramientas para afrontar...

Continue reading

¿Quieres recibir las novedades
de Beckley Med?

Esta web está protegida por reCAPTCHA. La política de privacidad y los términos del servicio de Google son aplicables.

Would you like to receive the latest news from Beckley Med?

This website is protected by reCAPTCHA. Google's privacy policy and terms of service apply.